Hughes Kakra, Guerrier Jean, Obirieze Augustine, Ngwang Dora, Rose David, Tran Daniel, Cornwell Edward, Obisesan Thomas, Preventza Ourania
Department of Surgery, Howard University College of Medicine, Washington, DC, USA
Department of Surgery, University of Virginia, Charlottesville, VA, USA.
Vasc Endovascular Surg. 2014 Jul-Aug;48(5-6):383-7. doi: 10.1177/1538574414540484. Epub 2014 Jun 19.
Endovascular repair of descending thoracic aortic aneurysms has become an acceptable surgical option over the past decade. We sought to compare the results of open versus endovascular repair of thoracic aortic aneurysms (TEVAR) in the United States.
The Nationwide Inpatient Sample (NIS) database was queried to identify all patients undergoing elective repair of a thoracic aortic aneurysm from 1998 to 2007 in the United States. Patient demographic data, preoperative comorbidities, and postoperative complications were recorded. Statistical analyses were performed comparing open versus endovascular repair. Multivariate analyses were conducted controlling for preoperative comorbidities including the presence of diabetes mellitus, cardiac, respiratory, and renal comorbidities as well as patient's age, gender, and ethnicity. The primary end point was mortality. Secondary end points were postoperative neurologic, cardiac, and respiratory complications.
There were 8967 patients who met the inclusion criteria. Of these patients, 8255 (92%) had an open repair and 712 (8%) had an endovascular repair. The overall mortality was 4.5% (4.6% for open and 3.6% for endovascular). On multivariate analysis, the odds of death were reduced by 46% among patients undergoing endovascular repair when compared to open repair (odds ratio [OR]: 0.54; P = .016). There was also reduced odds of a postoperative neurologic complication (OR: 0.48; P = .015), cardiac complication (OR: 0.24; P < .001), and respiratory complication (OR: 0.38: P = .001) in the endovascular group.
Nationwide data comparing open and TEVAR in the United States reveal decreased postoperative mortality and a decreased incidence of postoperative neurologic, cardiac, and respiratory complications for TEVAR.
在过去十年中,胸降主动脉瘤的血管腔内修复已成为一种可接受的手术选择。我们试图比较美国胸主动脉瘤开放修复与血管腔内修复(TEVAR)的结果。
查询全国住院患者样本(NIS)数据库,以识别1998年至2007年在美国接受胸主动脉瘤择期修复的所有患者。记录患者的人口统计学数据、术前合并症和术后并发症。进行统计分析以比较开放修复与血管腔内修复。进行多变量分析,控制术前合并症,包括糖尿病、心脏、呼吸和肾脏合并症以及患者的年龄、性别和种族。主要终点是死亡率。次要终点是术后神经、心脏和呼吸并发症。
有8967例患者符合纳入标准。其中,8255例(92%)接受了开放修复,712例(8%)接受了血管腔内修复。总体死亡率为4.5%(开放修复为4.6%,血管腔内修复为3.6%)。在多变量分析中,与开放修复相比,接受血管腔内修复的患者死亡几率降低了46%(优势比[OR]:0.54;P = 0.016)。血管腔内修复组术后神经并发症(OR:0.48;P = 0.015)、心脏并发症(OR:0.24;P < 0.001)和呼吸并发症(OR:0.38:P = 0.001)的几率也降低。
美国比较开放修复和TEVAR的全国性数据显示,TEVAR术后死亡率降低,术后神经、心脏和呼吸并发症的发生率降低。